News and publications

Invoke Bio Wins $100,000 QB3 Mentoring Program Award

Invoke Bio was awarded $100,000 through the QB3 Mentoring Program's Proof-of-Concept Award, supporting research and development for early-stage biotech companies. Co-Founder and CEO TJ Sears noted the funding will help catalyze the company's mission to deliver personalized immunotherapies for patients fighting cancer.

More news

Designing a Personalized Cancer Vaccine from Sid Sijbrandij's Data
Open Data
News
October 2026
Designing a Personalized Cancer Vaccine from Sid Sijbrandij's Data
Designing a Personalized Cancer Vaccine from Sid Sijbrandij's Data
Teaching Cancer Vaccines What to Target: Invoke Bio Turns to AI
QB3
News
October 2026
Teaching Cancer Vaccines What to Target: Invoke Bio Turns to AI
Teaching Cancer Vaccines What to Target: Invoke Bio Turns to AI
Learning What Cancer Reveals: Introducing NEMo
bioRxiv Preprint
Publication
September 2026
Learning What Cancer Reveals: Introducing NEMo
Learning What Cancer Reveals: Introducing NEMo
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
QB3
News
June 2026
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
See all
news